Selective implantation of durable left ventricular assist devices as primary therapy for refractory cardiogenic shock

Our data challenge the notion that patients in refractory cardiogenic shock are best served by an initial period of stabilization with temporary devices. Primary implantation of durable LVADs in cardiogenic shock can yield good midterm outcomes and may have potential benefits.